Status:
RECRUITING
Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Parotid Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Parotid neoplasm consists of a wide range of benign and malignant lesions, and parotidectomy has been the mainstay for management of these neoplasms. Within the parotid gland there are branches of the...
Eligibility Criteria
Inclusion
- Consecutive patients with parotid tumour diagnosed on other imaging modalities (such as ultrasonography or computed tomography), with or without cytological diagnosis from fine needle aspiration, will be recruited from the ear, nose and throat specialty clinic.
Exclusion
- Patients who are contraindicated to magnetic resonance imaging (such as due to underlying MRI incompatible metallic implants)
- Patient who are contraindicated to MRI contrast agents (such as advanced renal failure or previous severe allergic reaction)
- Patients who cannot cooperate for MRI scanning.
- Patients show are unable to provide informed consent.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05296109
Start Date
February 1 2022
End Date
June 30 2026
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gerald Choa MRI Center
Hong Kong, Hong Kong